Publication | Closed Access

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia

ThrombopoiesisThrombosisArgatroban TherapyAutoimmune DiseaseBlood PlateletMedicineImmunologyHematologyAnticoagulant ActivityAutoimmunityPharmacotherapyCoagulopathyHeparin-induced ThrombocytopeniaPlatelet AntagonistPharmacologyAnticoagulantHeparins